nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—ABCB1—Parkinson's disease	0.626	1	CbGaD
Boceprevir—CTSK—forelimb—Parkinson's disease	0.0234	0.125	CbGeAlD
Boceprevir—CTSL—embryo—Parkinson's disease	0.00798	0.0426	CbGeAlD
Boceprevir—CTSL—forebrain—Parkinson's disease	0.00705	0.0377	CbGeAlD
Boceprevir—CMA1—cardiovascular system—Parkinson's disease	0.00697	0.0373	CbGeAlD
Boceprevir—CTSV—medulla oblongata—Parkinson's disease	0.00624	0.0333	CbGeAlD
Boceprevir—CTSL—cardiovascular system—Parkinson's disease	0.00596	0.0319	CbGeAlD
Boceprevir—CTSV—midbrain—Parkinson's disease	0.0057	0.0305	CbGeAlD
Boceprevir—CTSV—spinal cord—Parkinson's disease	0.00556	0.0297	CbGeAlD
Boceprevir—CTSS—embryo—Parkinson's disease	0.00527	0.0281	CbGeAlD
Boceprevir—CTSL—medulla oblongata—Parkinson's disease	0.0051	0.0272	CbGeAlD
Boceprevir—CTSV—head—Parkinson's disease	0.00495	0.0264	CbGeAlD
Boceprevir—CTSV—nervous system—Parkinson's disease	0.00469	0.0251	CbGeAlD
Boceprevir—CTSL—midbrain—Parkinson's disease	0.00466	0.0249	CbGeAlD
Boceprevir—CTSS—forebrain—Parkinson's disease	0.00466	0.0249	CbGeAlD
Boceprevir—CTSL—spinal cord—Parkinson's disease	0.00454	0.0243	CbGeAlD
Boceprevir—CTSV—central nervous system—Parkinson's disease	0.00451	0.0241	CbGeAlD
Boceprevir—CTSK—cardiovascular system—Parkinson's disease	0.00449	0.024	CbGeAlD
Boceprevir—Telaprevir—ABCB1—Parkinson's disease	0.00446	1	CrCbGaD
Boceprevir—CTSL—head—Parkinson's disease	0.00404	0.0216	CbGeAlD
Boceprevir—CTSS—cardiovascular system—Parkinson's disease	0.00394	0.021	CbGeAlD
Boceprevir—CTSK—medulla oblongata—Parkinson's disease	0.00384	0.0205	CbGeAlD
Boceprevir—CTSL—nervous system—Parkinson's disease	0.00383	0.0205	CbGeAlD
Boceprevir—CTSL—central nervous system—Parkinson's disease	0.00369	0.0197	CbGeAlD
Boceprevir—CTSL—cerebellum—Parkinson's disease	0.0036	0.0193	CbGeAlD
Boceprevir—CTSV—brain—Parkinson's disease	0.00358	0.0192	CbGeAlD
Boceprevir—CTSK—spinal cord—Parkinson's disease	0.00342	0.0183	CbGeAlD
Boceprevir—CTSS—medulla oblongata—Parkinson's disease	0.00336	0.018	CbGeAlD
Boceprevir—CTSS—midbrain—Parkinson's disease	0.00308	0.0164	CbGeAlD
Boceprevir—CTSK—head—Parkinson's disease	0.00304	0.0163	CbGeAlD
Boceprevir—CTSS—spinal cord—Parkinson's disease	0.003	0.016	CbGeAlD
Boceprevir—CTSL—brain—Parkinson's disease	0.00293	0.0156	CbGeAlD
Boceprevir—CTSK—nervous system—Parkinson's disease	0.00289	0.0154	CbGeAlD
Boceprevir—CTSK—central nervous system—Parkinson's disease	0.00278	0.0148	CbGeAlD
Boceprevir—CTSK—cerebellum—Parkinson's disease	0.00272	0.0145	CbGeAlD
Boceprevir—CTSS—head—Parkinson's disease	0.00267	0.0143	CbGeAlD
Boceprevir—CTSS—nervous system—Parkinson's disease	0.00253	0.0135	CbGeAlD
Boceprevir—CTSS—central nervous system—Parkinson's disease	0.00243	0.013	CbGeAlD
Boceprevir—CTSS—cerebellum—Parkinson's disease	0.00238	0.0127	CbGeAlD
Boceprevir—CTSK—brain—Parkinson's disease	0.00221	0.0118	CbGeAlD
Boceprevir—CTSS—brain—Parkinson's disease	0.00193	0.0103	CbGeAlD
Boceprevir—ABCB1—embryo—Parkinson's disease	0.000929	0.00496	CbGeAlD
Boceprevir—ABCB1—forebrain—Parkinson's disease	0.000822	0.00439	CbGeAlD
Boceprevir—ABCB1—cardiovascular system—Parkinson's disease	0.000695	0.00371	CbGeAlD
Boceprevir—CYP3A4—nervous system—Parkinson's disease	0.00063	0.00337	CbGeAlD
Boceprevir—CYP3A4—central nervous system—Parkinson's disease	0.000607	0.00324	CbGeAlD
Boceprevir—ABCB1—medulla oblongata—Parkinson's disease	0.000594	0.00317	CbGeAlD
Boceprevir—ABCB1—midbrain—Parkinson's disease	0.000543	0.0029	CbGeAlD
Boceprevir—ABCB1—spinal cord—Parkinson's disease	0.000529	0.00283	CbGeAlD
Boceprevir—ABCB1—head—Parkinson's disease	0.00047	0.00251	CbGeAlD
Boceprevir—CTSV—Immune System—PLA2G6—Parkinson's disease	0.000464	0.00254	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PLA2G6—Parkinson's disease	0.000464	0.00254	CbGpPWpGaD
Boceprevir—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000451	0.00247	CbGpPWpGaD
Boceprevir—ABCB1—nervous system—Parkinson's disease	0.000446	0.00238	CbGeAlD
Boceprevir—ABCB1—Allograft Rejection—HLA-DRA—Parkinson's disease	0.000444	0.00244	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—ADRBK1—Parkinson's disease	0.000439	0.00241	CbGpPWpGaD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000433	0.00237	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—ABL1—Parkinson's disease	0.000432	0.00237	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—ABL1—Parkinson's disease	0.000432	0.00237	CbGpPWpGaD
Boceprevir—ABCB1—central nervous system—Parkinson's disease	0.000429	0.0023	CbGeAlD
Boceprevir—CTSK—Immune System—DCTN1—Parkinson's disease	0.000427	0.00234	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PARK2—Parkinson's disease	0.000423	0.00232	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PARK2—Parkinson's disease	0.000423	0.00232	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RIT2—Parkinson's disease	0.00042	0.0023	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGF20—Parkinson's disease	0.00042	0.0023	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGF20—Parkinson's disease	0.00042	0.0023	CbGpPWpGaD
Boceprevir—ABCB1—cerebellum—Parkinson's disease	0.00042	0.00224	CbGeAlD
Boceprevir—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000413	0.00227	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—MAPK8—Parkinson's disease	0.000412	0.00226	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GRK5—Parkinson's disease	0.000398	0.00218	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—CASP3—Parkinson's disease	0.000397	0.00218	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—CASP3—Parkinson's disease	0.000397	0.00218	CbGpPWpGaD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000396	0.00217	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HLA-DRA—Parkinson's disease	0.000388	0.00213	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.000385	0.00211	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.000385	0.00211	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PLA2G6—Parkinson's disease	0.000384	0.00211	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—CASP3—Parkinson's disease	0.000369	0.00203	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—ADRBK1—Parkinson's disease	0.000362	0.00198	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—IL6—Parkinson's disease	0.000358	0.00196	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—ABL1—Parkinson's disease	0.000358	0.00196	CbGpPWpGaD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000358	0.00196	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GRM4—Parkinson's disease	0.000357	0.00196	CbGpPWpGaD
Boceprevir—CTSS—Immune System—DCTN1—Parkinson's disease	0.000352	0.00193	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PARK2—Parkinson's disease	0.000351	0.00192	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—Parkinson's disease	0.000349	0.00192	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—IGF2—Parkinson's disease	0.000349	0.00192	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGF20—Parkinson's disease	0.000348	0.00191	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—GSTA4—Parkinson's disease	0.000347	0.0019	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000342	0.00188	CbGpPWpGaD
Boceprevir—ABCB1—brain—Parkinson's disease	0.000341	0.00182	CbGeAlD
Boceprevir—CMA1—Signaling Pathways—PENK—Parkinson's disease	0.000339	0.00186	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAG—Parkinson's disease	0.000339	0.00186	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—CASP3—Parkinson's disease	0.000329	0.00181	CbGpPWpGaD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000326	0.00179	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-DRA—Parkinson's disease	0.00032	0.00175	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.000319	0.00175	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PLA2G6—Parkinson's disease	0.000317	0.00174	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PDYN—Parkinson's disease	0.00031	0.0017	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—MAOB—Parkinson's disease	0.000309	0.0017	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ADRBK1—Parkinson's disease	0.000309	0.00169	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ADRBK1—Parkinson's disease	0.000309	0.00169	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—ABL1—Parkinson's disease	0.000295	0.00162	CbGpPWpGaD
Boceprevir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000293	0.00161	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GFAP—Parkinson's disease	0.000291	0.0016	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PARK2—Parkinson's disease	0.000289	0.00158	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GRM5—Parkinson's disease	0.000288	0.00158	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGF20—Parkinson's disease	0.000287	0.00157	CbGpPWpGaD
Boceprevir—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000281	0.00154	CbGpPWpGaD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000279	0.00153	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Parkinson's disease	0.000278	0.00152	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—CASP3—Parkinson's disease	0.000271	0.00149	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000271	0.00148	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.000263	0.00144	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—EDN1—Parkinson's disease	0.000262	0.00144	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ADRBK1—Parkinson's disease	0.000256	0.0014	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGF20—Parkinson's disease	0.000252	0.00138	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ABL1—Parkinson's disease	0.000252	0.00138	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ABL1—Parkinson's disease	0.000252	0.00138	CbGpPWpGaD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000248	0.00136	CbGpPWpGaD
Boceprevir—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000245	0.00134	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000245	0.00134	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HGF—Parkinson's disease	0.000237	0.0013	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HGF—Parkinson's disease	0.000237	0.0013	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000235	0.00129	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—INS—Parkinson's disease	0.000232	0.00127	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—CYP2D6—Parkinson's disease	0.00023	0.00126	CbGpPWpGaD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000227	0.00125	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000227	0.00124	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—INSR—Parkinson's disease	0.000226	0.00124	CbGpPWpGaD
Boceprevir—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000224	0.00123	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGB—Parkinson's disease	0.000214	0.00117	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HTR1A—Parkinson's disease	0.000212	0.00116	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ADRBK1—Parkinson's disease	0.000211	0.00115	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—CYP2E1—Parkinson's disease	0.00021	0.00115	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TAC1—Parkinson's disease	0.000209	0.00115	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ABL1—Parkinson's disease	0.000208	0.00114	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.000208	0.00114	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000207	0.00114	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—DRD1—Parkinson's disease	0.000205	0.00112	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000201	0.0011	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—DRD3—Parkinson's disease	0.000199	0.00109	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HGF—Parkinson's disease	0.000196	0.00107	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—MAPK8—Parkinson's disease	0.000195	0.00107	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—MAPK8—Parkinson's disease	0.000195	0.00107	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000195	0.00107	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000186	0.00102	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000184	0.00101	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—DRD2—Parkinson's disease	0.00018	0.000985	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HTR7—Parkinson's disease	0.00018	0.000985	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—COMT—Parkinson's disease	0.000174	0.000956	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—GSTP1—Parkinson's disease	0.000173	0.000951	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—MAOA—Parkinson's disease	0.000173	0.000949	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—COMT—Parkinson's disease	0.000172	0.000943	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ABL1—Parkinson's disease	0.000172	0.000941	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000171	0.000938	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000162	0.00089	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000162	0.00089	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MAPK8—Parkinson's disease	0.000162	0.000887	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HGF—Parkinson's disease	0.000161	0.000885	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000161	0.000885	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—GSTM1—Parkinson's disease	0.000159	0.000874	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000159	0.000873	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000157	0.000862	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000151	0.000831	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IGF2—Parkinson's disease	0.000151	0.000826	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IGF1R—Parkinson's disease	0.000146	0.000798	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000144	0.000789	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EDN1—Parkinson's disease	0.000144	0.000789	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MAPK8—Parkinson's disease	0.000133	0.000731	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NGF—Parkinson's disease	0.000132	0.000725	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HTR2A—Parkinson's disease	0.000126	0.00069	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—Parkinson's disease	0.000125	0.000684	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—Parkinson's disease	0.000125	0.000684	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1B—Parkinson's disease	0.000124	0.00068	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1B—Parkinson's disease	0.000124	0.00068	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000118	0.000645	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	0.000118	0.000645	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	0.000117	0.000643	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APOE—Parkinson's disease	0.000117	0.000641	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000116	0.000635	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MAPK8—Parkinson's disease	0.000114	0.000624	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK8—Parkinson's disease	0.000114	0.000624	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ND3—Parkinson's disease	0.000113	0.00062	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MCCC1—Parkinson's disease	0.000113	0.00062	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000107	0.000586	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—OMD—Parkinson's disease	0.000106	0.000583	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TALDO1—Parkinson's disease	0.000106	0.000583	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000105	0.000578	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IL6—Parkinson's disease	0.000103	0.000567	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000103	0.000564	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1B—Parkinson's disease	0.000103	0.000564	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	0.000101	0.000552	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—INS—Parkinson's disease	9.99e-05	0.000548	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	9.78e-05	0.000536	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.64e-05	0.000529	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GCH1—Parkinson's disease	9.61e-05	0.000527	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MAPK8—Parkinson's disease	9.43e-05	0.000517	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	8.61e-05	0.000472	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—FBP1—Parkinson's disease	8.57e-05	0.00047	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—DBH—Parkinson's disease	8.57e-05	0.00047	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GBA—Parkinson's disease	8.57e-05	0.00047	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—Parkinson's disease	8.53e-05	0.000468	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MCCC1—Parkinson's disease	8.53e-05	0.000468	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ND3—Parkinson's disease	8.53e-05	0.000468	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—Parkinson's disease	8.51e-05	0.000467	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1B—Parkinson's disease	8.47e-05	0.000464	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—COMT—Parkinson's disease	8.1e-05	0.000444	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	8.06e-05	0.000442	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	8.05e-05	0.000441	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TALDO1—Parkinson's disease	8.02e-05	0.00044	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—OMD—Parkinson's disease	8.02e-05	0.00044	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	7.99e-05	0.000438	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	7.95e-05	0.000436	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	7.93e-05	0.000435	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK8—Parkinson's disease	7.76e-05	0.000426	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NDUFB11—Parkinson's disease	7.6e-05	0.000417	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CASP3—Parkinson's disease	7.44e-05	0.000408	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	7.41e-05	0.000406	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	7.31e-05	0.000401	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—Parkinson's disease	7.27e-05	0.000398	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—Parkinson's disease	7.27e-05	0.000398	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GCH1—Parkinson's disease	7.25e-05	0.000398	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK8—Parkinson's disease	6.84e-05	0.000375	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GBA—Parkinson's disease	6.46e-05	0.000354	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—FBP1—Parkinson's disease	6.46e-05	0.000354	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—DBH—Parkinson's disease	6.46e-05	0.000354	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—DDC—Parkinson's disease	6.29e-05	0.000345	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—Parkinson's disease	6.02e-05	0.00033	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTA4—Parkinson's disease	5.94e-05	0.000326	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	5.79e-05	0.000317	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.65e-05	0.00031	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.42e-05	0.000297	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	5.35e-05	0.000293	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	5.32e-05	0.000292	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MAOB—Parkinson's disease	5.29e-05	0.00029	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ND3—Parkinson's disease	5.25e-05	0.000288	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MCCC1—Parkinson's disease	5.25e-05	0.000288	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—Parkinson's disease	4.96e-05	0.000272	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—OMD—Parkinson's disease	4.94e-05	0.000271	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.94e-05	0.000271	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—DDC—Parkinson's disease	4.74e-05	0.00026	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.71e-05	0.000258	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.68e-05	0.000257	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA4—Parkinson's disease	4.48e-05	0.000246	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.47e-05	0.000245	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—Parkinson's disease	4.37e-05	0.000239	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	4.21e-05	0.000231	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLA2G6—Parkinson's disease	4.03e-05	0.000221	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MAOB—Parkinson's disease	3.99e-05	0.000219	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.98e-05	0.000218	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—DBH—Parkinson's disease	3.98e-05	0.000218	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GBA—Parkinson's disease	3.98e-05	0.000218	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	3.93e-05	0.000216	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CTGF—Parkinson's disease	3.86e-05	0.000212	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	3.6e-05	0.000197	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NQO1—Parkinson's disease	3.56e-05	0.000195	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TH—Parkinson's disease	3.51e-05	0.000192	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYCS—Parkinson's disease	3.37e-05	0.000185	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—COMT—Parkinson's disease	2.98e-05	0.000163	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.97e-05	0.000163	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTP1—Parkinson's disease	2.97e-05	0.000163	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MAOA—Parkinson's disease	2.96e-05	0.000162	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HMOX1—Parkinson's disease	2.93e-05	0.00016	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—DDC—Parkinson's disease	2.92e-05	0.00016	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CTGF—Parkinson's disease	2.91e-05	0.00016	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCB1—Parkinson's disease	2.81e-05	0.000154	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.76e-05	0.000151	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTM1—Parkinson's disease	2.73e-05	0.000149	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2E1—Parkinson's disease	2.71e-05	0.000149	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NQO1—Parkinson's disease	2.68e-05	0.000147	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TH—Parkinson's disease	2.65e-05	0.000145	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPX1—Parkinson's disease	2.61e-05	0.000143	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYCS—Parkinson's disease	2.54e-05	0.000139	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.49e-05	0.000136	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.46e-05	0.000135	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTHFR—Parkinson's disease	2.41e-05	0.000132	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—COMT—Parkinson's disease	2.25e-05	0.000123	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOE—Parkinson's disease	2.24e-05	0.000123	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.24e-05	0.000123	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MAOA—Parkinson's disease	2.23e-05	0.000122	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.21e-05	0.000121	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.06e-05	0.000113	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPX1—Parkinson's disease	1.97e-05	0.000108	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—INS—Parkinson's disease	1.92e-05	0.000105	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.83e-05	0.0001	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.82e-05	9.97e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.79e-05	9.84e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOE—Parkinson's disease	1.69e-05	9.28e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.67e-05	9.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.65e-05	9.07e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TH—Parkinson's disease	1.63e-05	8.94e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.56e-05	8.58e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—INS—Parkinson's disease	1.45e-05	7.93e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—COMT—Parkinson's disease	1.39e-05	7.6e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.38e-05	7.56e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.38e-05	7.54e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.36e-05	7.46e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.31e-05	7.16e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.27e-05	6.95e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.21e-05	6.65e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.12e-05	6.14e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOE—Parkinson's disease	1.04e-05	5.72e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—INS—Parkinson's disease	8.91e-06	4.88e-05	CbGpPWpGaD
